• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Generic version of tamsulosin for BPH granted FDA approval

Article

The FDA has approved the first generic version of tamsulosin hydrochloride capsules, 0.4 mg, to treat BPH.

The FDA has approved the first generic version of tamsulosin hydrochloride capsules, 0.4 mg, to treat BPH.

"The approval of generic tamsulosin offers greater access to a widely used treatment for BPH," said Gary Buehler, RPh, of the FDA’s Office of Generic Drugs. "FDA is committed to making generic drugs available to patients and these drugs meet the same rigid standards as the brand name drugs."

The prescribing information and safety warnings for the generic version of tamsulosin are the same as those for the brand-name version. Generic tamsulosin capsules are manufactured by IMPAX Laboratories, Inc., of Hayward, CA.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.